... Irish business was so strong during the 1990s that this period of rapid economic growth became known by the term Celtic Tiger. This period continued into the next century, slowing in 2001 before picking up again and finally slowing down in 2007. The provi...

...week's deal with Johnson & Johnson (J&J) vindicates the strategy pursued by Kelly Martin during his six years as boss of the Irish-based pharmaceutical company. This week Elan announced a deal with J&J. Not alone does the J&J deal wipe out most of Elan's $1.4bn...

...that ended Thursday and the subsequent offering period for the remaining shares will expire on July 9. In May, Johnson & Johnson had agreed to buy cancer drug developer Cougar Biotechnology for about $970 million in cash. To read more, double click on [ID:nBNG512920] ...

...forward. Patent Infringement Hurts Humira On Monday, a federal jury dealt Abbott a glancing blow when it upheld a patent on Johnson & Johnson's (NYSE:JNJ) arthritis treatment Remicade. The Texas jury ordered Abbott to pay J&J $1.67 billion for its alleged...

...over age 60, people taking steroids, or persons who have had a kidney, heart or lung transplant, the plaintiffs allege. Johnson & Johnson had supported mass-tort designation but asked for venue in Middlesex County, N.J., where its headquarters is located,...

...Procter & Gamble (PG) in men's shave products, in June acquired the Edge and Skintimate shave preparation business from Johnson & Johnson (JNJ) for an aggregate purchase price of $275 million. Through the acquisition, ENR will be adding shaving creams and...

...Wednesday, July 22, 2009. Cougar Biotechnology, Inc. (NASDAQ: CGRB) announced today that the initial offering period of Johnson & Johnson's (NYSE: JNJ) tender offer for all the outstanding shares of Cougar common stock expired at midnight (Eastern time) on...

...gone. State-side: California is taking desperate measures in order to cope with a huge deficit. R&D deal: US drug maker Johnson & Johnson is to take over some of Elan's research into the treatment of Alzheimer's disease At 10am on Sundays, The Business is...

...initial charter members include the Wake Forest Institute for Regenerative Medicine, Stanford University, Geron, Johnson & Johnson, and Aldagen. Investor organizations include Kleiner, Perkins and Proteus Ventures. “Regenerative medicine holds enormous promise,”...

...* Says subsequent offering period ends on July 9 * Gets commitments to tender 2 mln more shares July 3 (Reuters) - Johnson & Johnson (JNJ.N) said about 84.4 percent of the outstanding shares of Cougar Biotechnology Inc (CGRB.O) were tendered during the initial...